Cargando…

Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein

Emerging and re-emerging viral infections have been an important public health problem in recent years. We focused our attention on Toscana virus (TOSV), an emergent neurotropic negative-strand RNA virus of the Phenuiviridae family. The mechanisms of protection against phlebovirus natural infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandolfo, Claudia, Prathyumn, Shibily, Terrosi, Chiara, Anichini, Gabriele, Gori Savellini, Gianni, Corti, Davide, Bracci, Luisa, Lanzavecchia, Antonio, Roman-Sosa, Gleyder, Cusi, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402642/
https://www.ncbi.nlm.nih.gov/pubmed/34452049
http://dx.doi.org/10.3390/vaccines9080924
_version_ 1783745840109584384
author Gandolfo, Claudia
Prathyumn, Shibily
Terrosi, Chiara
Anichini, Gabriele
Gori Savellini, Gianni
Corti, Davide
Bracci, Luisa
Lanzavecchia, Antonio
Roman-Sosa, Gleyder
Cusi, Maria Grazia
author_facet Gandolfo, Claudia
Prathyumn, Shibily
Terrosi, Chiara
Anichini, Gabriele
Gori Savellini, Gianni
Corti, Davide
Bracci, Luisa
Lanzavecchia, Antonio
Roman-Sosa, Gleyder
Cusi, Maria Grazia
author_sort Gandolfo, Claudia
collection PubMed
description Emerging and re-emerging viral infections have been an important public health problem in recent years. We focused our attention on Toscana virus (TOSV), an emergent neurotropic negative-strand RNA virus of the Phenuiviridae family. The mechanisms of protection against phlebovirus natural infection are not known; however, it is supposed that a virus-neutralizing antibody response against viral glycoproteins would be useful to block the first stages of infection. By using an improved memory B cell immortalization method, we obtained a panel of human mAbs which reacted with TOSV antigens. We identified three epitopes of TOSV Gn glycoproteins by neutralizing mAbs using synthetic peptide arrays on membrane support (SPOT synthesis). These epitopes, separated in primary structure, might be exposed near one another as a conformational epitope in their native structure. In vivo studies were conducted to evaluate the humoral response elicited in mice immunized with the identified peptides. The results underlined the hypothesis that the first two peptides located in the NH(2) terminus could form a conformational epitope, while the third, located near the transmembrane sequence in the carboxyl terminus, was necessary to strengthen neutralizing activity. Our results emphasize the importance of identifying neutralizing epitopes shared among the various phleboviruses, which could be exploited for the development of a potential epitope-based diagnostic assay or a polyvalent protective vaccine against different phleboviruses.
format Online
Article
Text
id pubmed-8402642
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84026422021-08-29 Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein Gandolfo, Claudia Prathyumn, Shibily Terrosi, Chiara Anichini, Gabriele Gori Savellini, Gianni Corti, Davide Bracci, Luisa Lanzavecchia, Antonio Roman-Sosa, Gleyder Cusi, Maria Grazia Vaccines (Basel) Article Emerging and re-emerging viral infections have been an important public health problem in recent years. We focused our attention on Toscana virus (TOSV), an emergent neurotropic negative-strand RNA virus of the Phenuiviridae family. The mechanisms of protection against phlebovirus natural infection are not known; however, it is supposed that a virus-neutralizing antibody response against viral glycoproteins would be useful to block the first stages of infection. By using an improved memory B cell immortalization method, we obtained a panel of human mAbs which reacted with TOSV antigens. We identified three epitopes of TOSV Gn glycoproteins by neutralizing mAbs using synthetic peptide arrays on membrane support (SPOT synthesis). These epitopes, separated in primary structure, might be exposed near one another as a conformational epitope in their native structure. In vivo studies were conducted to evaluate the humoral response elicited in mice immunized with the identified peptides. The results underlined the hypothesis that the first two peptides located in the NH(2) terminus could form a conformational epitope, while the third, located near the transmembrane sequence in the carboxyl terminus, was necessary to strengthen neutralizing activity. Our results emphasize the importance of identifying neutralizing epitopes shared among the various phleboviruses, which could be exploited for the development of a potential epitope-based diagnostic assay or a polyvalent protective vaccine against different phleboviruses. MDPI 2021-08-19 /pmc/articles/PMC8402642/ /pubmed/34452049 http://dx.doi.org/10.3390/vaccines9080924 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gandolfo, Claudia
Prathyumn, Shibily
Terrosi, Chiara
Anichini, Gabriele
Gori Savellini, Gianni
Corti, Davide
Bracci, Luisa
Lanzavecchia, Antonio
Roman-Sosa, Gleyder
Cusi, Maria Grazia
Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
title Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
title_full Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
title_fullStr Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
title_full_unstemmed Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
title_short Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
title_sort identification of a neutralizing epitope on tosv gn glycoprotein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402642/
https://www.ncbi.nlm.nih.gov/pubmed/34452049
http://dx.doi.org/10.3390/vaccines9080924
work_keys_str_mv AT gandolfoclaudia identificationofaneutralizingepitopeontosvgnglycoprotein
AT prathyumnshibily identificationofaneutralizingepitopeontosvgnglycoprotein
AT terrosichiara identificationofaneutralizingepitopeontosvgnglycoprotein
AT anichinigabriele identificationofaneutralizingepitopeontosvgnglycoprotein
AT gorisavellinigianni identificationofaneutralizingepitopeontosvgnglycoprotein
AT cortidavide identificationofaneutralizingepitopeontosvgnglycoprotein
AT bracciluisa identificationofaneutralizingepitopeontosvgnglycoprotein
AT lanzavecchiaantonio identificationofaneutralizingepitopeontosvgnglycoprotein
AT romansosagleyder identificationofaneutralizingepitopeontosvgnglycoprotein
AT cusimariagrazia identificationofaneutralizingepitopeontosvgnglycoprotein